AAAAAA
Results: 1-25/63
Authors:
Xie, CS
Lovell, MA
Xiong, SL
Kindy, MS
Guo, JT
Xie, J
Amaranth, V
Montine, TJ
Markesbery, WR
Citation: Cs. Xie et al., Expression of glutathione-S-transferase isozyme in the SY5Y neuroblastoma cell, line increases resistance to oxidative stress, FREE RAD B, 31(1), 2001, pp. 73-81
Authors:
Aksenov, MY
Aksenova, MV
Butterfield, DA
Geddes, JW
Markesbery, WR
Citation: My. Aksenov et al., Protein oxidation in the brain in Alzheimer's disease, NEUROSCIENC, 103(2), 2001, pp. 373-383
Authors:
Aksenov, MY
Markesbery, WR
Citation: My. Aksenov et Wr. Markesbery, Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease, NEUROSCI L, 302(2-3), 2001, pp. 141-145
Authors:
Robertson, JD
Lovell, MA
Buchholz, B
Xie, CS
Markesbery, WR
Citation: Jd. Robertson et al., Use of bomb pulse C-14 to age senile plaques and neurofibrillary tangles in the Alzheimer's disease brain, J RAD NUCL, 249(2), 2001, pp. 443-447
Authors:
Lovell, MA
Xie, CS
Markesbery, WR
Citation: Ma. Lovell et al., Acrolein is increased in Alzheimer's disease brain and is toxic to primaryhippocampal cultures, NEUROBIOL A, 22(2), 2001, pp. 187-194
Authors:
Gosche, KM
Mortimer, JA
Smith, CD
Markesbery, WR
Snowdon, DA
Citation: Km. Gosche et al., An automated technique for measuring hippocampal volumes from MR imaging studies, AM J NEUROR, 22(9), 2001, pp. 1686-1689
Authors:
Petrovitch, H
White, LR
Ross, GW
Steinhorn, SC
Li, CY
Masaki, KH
Davis, DG
Nelson, J
Hardman, J
Curb, JD
Blanchette, PL
Launer, LJ
Yano, K
Markesbery, WR
Citation: H. Petrovitch et al., Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study, NEUROLOGY, 57(2), 2001, pp. 226-234
Authors:
Picklo, MJ
Olson, SJ
Markesbery, WR
Montine, TJ
Citation: Mj. Picklo et al., Expression and activities of aldo-keto oxidoreductases in Alzheimer disease, J NE EXP NE, 60(7), 2001, pp. 686-695
Authors:
Lauderback, CM
Hackett, JM
Huang, FF
Keller, JN
Szweda, LI
Markesbery, WR
Butterfield, DA
Citation: Cm. Lauderback et al., The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of A beta 1-42, J NEUROCHEM, 78(2), 2001, pp. 413-416
Authors:
Schmitt, FA
Wetherby, MMC
Wekstein, DR
Dearth, CMS
Markesbery, WR
Citation: Fa. Schmitt et al., Brain donation in normal aging: Procedures, motivations, and donor characteristics from the biologically resilient adults in neurological studies (BRAiNS) project, GERONTOLOGI, 41(6), 2001, pp. 716-722
Authors:
Picklo, MJ
Olson, SJ
Hayes, JD
Markesbery, WR
Montine, TJ
Citation: Mj. Picklo et al., Elevation of AKR7A2 (succinic semialdehyde reductase) in neurodegenerativedisease, BRAIN RES, 916(1-2), 2001, pp. 229-238
Authors:
Lauderback, CM
Hackett, JM
Keller, JN
Varadarajan, S
Szweda, L
Kindy, M
Markesbery, WR
Butterfield, DA
Citation: Cm. Lauderback et al., Vulnerability of synaptosomes from ApoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): Implications for Alzheimer's disease, BIOCHEM, 40(8), 2001, pp. 2548-2554
Authors:
Lovell, MA
Markesbery, WR
Citation: Ma. Lovell et Wr. Markesbery, Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid, ARCH NEUROL, 58(3), 2001, pp. 392-396
Authors:
Reich, EE
Markesbery, WR
Roberts, LJ
Swift, LL
Morrow, JD
Montine, TJ
Citation: Ee. Reich et al., Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease, AM J PATH, 158(1), 2001, pp. 293-297
Authors:
Wackerbarth, SB
Johnson, MMS
Markesbery, WR
Smith, CD
Citation: Sb. Wackerbarth et al., Urban-rural differences in a memory disorders clinical population, J AM GER SO, 49(5), 2001, pp. 647-650
Authors:
Markesbery, WR
Montine, TJ
Lovell, MA
Citation: Wr. Markesbery et al., Oxidative alterations in neurodegenerative diseases, CONT NEUROS, 2001, pp. 21-51
Authors:
Markesbery, WR
Citation: Wr. Markesbery, Overview of vascular dementia, ALZHEIMER'S DISEASE, 2001, pp. 205-218
Authors:
Smith, CD
Snowdon, D
Markesbery, WR
Citation: Cd. Smith et al., Periventricular white matter hyperintensities on MRI: Correlation with neuropathologic findings, J NEUROIMAG, 10(1), 2000, pp. 13-16
Authors:
Lovell, MA
Xie, CS
Markesbery, WR
Citation: Ma. Lovell et al., Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures, FREE RAD B, 29(8), 2000, pp. 714-720
Authors:
Xie, CS
Markesbery, WR
Lovell, MA
Citation: Cs. Xie et al., Survival of hippocampal and cortical neurons in a mixture of MEM+ and B27-supplemented neurobasal medium, FREE RAD B, 28(5), 2000, pp. 665-672
Authors:
Lovell, MA
Xie, CS
Gabbita, SP
Markesbery, WR
Citation: Ma. Lovell et al., Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain, FREE RAD B, 28(3), 2000, pp. 418-427
Authors:
Keller, JN
Markesbery, WR
Citation: Jn. Keller et Wr. Markesbery, Proteasome inhibition results in increased poly-ADP-ribosylation: Implications for neuron death, J NEUROSC R, 61(4), 2000, pp. 436-442
Authors:
Keller, JN
Huang, FF
Markesbery, WR
Citation: Jn. Keller et al., Decreased levels of proteasome activity and proteasome expression in agingspinal cord, NEUROSCIENC, 98(1), 2000, pp. 149-156
Authors:
Rulon, LL
Robertson, JD
Lovell, MA
Deibel, MA
Ehmann, WD
Markesbery, WR
Citation: Ll. Rulon et al., Serum zinc levels and Alzheimer's disease, BIOL TR EL, 75(1-3), 2000, pp. 79-85
Authors:
Keller, JN
Hanni, KB
Markesbery, WR
Citation: Jn. Keller et al., Possible involvement of proteasome inhibition in aging: implications for oxidative stress, MECH AGE D, 113(1), 2000, pp. 61-70